Search

Search Constraints

You searched for: Author/Creator Dufresne, A

Search Results

1. 1613PDmTOR inhibitors in uterine and extra-uterine malignant PEComas: A multicenter international case series retrospective analysis. (23rd October 2018)

2. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

3. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

10. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. (5th June 2019)